We previously reported high counts of CD4−CD8− double-negative αβ T cells with high levels of Ki67 (a proliferation marker) expression in two cohorts of cancer patients 1 mo after PD-1 blockade monotherapy (Ogishi et al., 2021). This evidence concerns the gene PDCD1 and cancer.